{
  "data": {
    "broad_sector": "PHARMA",
    "niche_industry": "Generic Formulations & Respiratory",
    "sector_kpis": {
      "kpi_1": "North America Revenue: $237 Mn (Q2 FY25)",
      "kpi_2": "EBITDA Margin: 26.7% (Highest-ever quarterly)",
      "kpi_3": "India Business Growth: 5% YoY (Chronic therapies outpaced market)"
    },
    "moat_rating": "Narrow",
    "competitive_position": "LEADER"
  },
  "_cached_at": "2025-12-24T22:15:24.728216",
  "_symbol": "CIPLA"
}